The number of people receiving treatment for advanced kidney failure—such as dialysis or kidney transplant—will double to over five million by 2030, mostly in developing regions such as Asia and Africa, a study said on Saturday.
Renal replacement therapy (RRT), through either dialysis or renal transplantation, is a life-saving yet high-cost treatment for people with end-stage kidney disease.
According to the latest research by the George Institute for Global Health published in The Lancet, the number of people receiving RRT is projected to grow from 2.618 million in 2010 to 5.439 million by 2030.
“However, the number of people without access to RRT will remain substantial,” the study titled Worldwide access to treatment for end-stage kidney disease: a systematic review said.
